Effect of Helicobacter pylori eradication according to the IL-8-251 polymorphism in Koreans

J Korean Med Sci. 2012 Oct;27(10):1202-7. doi: 10.3346/jkms.2012.27.10.1202. Epub 2012 Oct 2.

Abstract

Previous studies suggested that polymorphisms of proinflammatory cytokine genes are important host genetic factors in Helicobacter pylori infection. The present study evaluated whether IL-8-251 polymorphism affected H. pylori eradication rate and to investigate the effect of H. pylori eradication on angiogenesis and the inflammatory process according to the IL-8-251 polymorphism. A total of 250 H. pylori-positive patients treated by endoscopic resection of the gastric neoplasm were classified into 3 groups (134 H. pylori-eradicated group, 19 H. pylori-eradication failure group, and 97 H. pylori-infected group). H. pylori status, histology, and angiogenic factor levels were evaluated at baseline, 6 months, and 18 months. H. pylori eradication rate was 92.9% in AA genotype, 85.7% in AT genotype and 88.4% in TT genotype (P value = 0.731). Elevated IL-8 and matrix metalloproteinase-9 concentrations in H. pylori-infected gastric mucosa were reversible by successful eradication of H. pylori, independent of the IL-8-251 polymorphism. It is suggested that elevated IL-8 and MMP-9 concentrations in H. pylori-infected gastric mucosa are altered significantly after successful eradication and these conditions continue for 18 months. However, IL-8-251 polymorphism does not affect H. pylori eradication rate and the sequential changes of related angiogenic factors after H. pylori eradication in Koreans.

Keywords: Helicobacter pylori; Interleukin-8; Polymorphism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alleles
  • Angiopoietin-1 / analysis
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Asian People / genetics*
  • Female
  • Gastric Mucosa / metabolism
  • Gastric Mucosa / pathology
  • Genotype
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori*
  • Humans
  • Interleukin-8 / analysis
  • Interleukin-8 / genetics*
  • Male
  • Matrix Metalloproteinase 9 / analysis
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Proton Pump Inhibitors / therapeutic use
  • Republic of Korea
  • Retrospective Studies
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery
  • Time Factors
  • Vascular Endothelial Growth Factor A / analysis

Substances

  • Angiopoietin-1
  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Interleukin-8
  • Proton Pump Inhibitors
  • Vascular Endothelial Growth Factor A
  • Matrix Metalloproteinase 9